Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF). This independent panel of experts in preventive and primary care ...

Prostate cancer is one of the most common and deadly forms of cancer in men, yet early detection remains a major challenge. That difficulty lies in how subtle the disease can be in its earliest stages ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.